nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—Glucosamine—IFNG—psoriasis	0.015	0.705	CrCbGaD
Vidarabine—Glucosamine—TNF—psoriasis	0.00629	0.295	CrCbGaD
Vidarabine—Bradycardia—Dexamethasone—psoriasis	0.00114	0.00116	CcSEcCtD
Vidarabine—Bradycardia—Betamethasone—psoriasis	0.00114	0.00116	CcSEcCtD
Vidarabine—Hypersensitivity—Hydroxyurea—psoriasis	0.00114	0.00116	CcSEcCtD
Vidarabine—Syncope—Mycophenolate mofetil—psoriasis	0.00112	0.00115	CcSEcCtD
Vidarabine—Cough—Cyclosporine—psoriasis	0.00112	0.00114	CcSEcCtD
Vidarabine—Mood swings—Methotrexate—psoriasis	0.00112	0.00114	CcSEcCtD
Vidarabine—Convulsion—Cyclosporine—psoriasis	0.00111	0.00114	CcSEcCtD
Vidarabine—Asthenia—Hydroxyurea—psoriasis	0.00111	0.00113	CcSEcCtD
Vidarabine—Hypertension—Cyclosporine—psoriasis	0.00111	0.00113	CcSEcCtD
Vidarabine—Pain—Mycophenolic acid—psoriasis	0.00111	0.00113	CcSEcCtD
Vidarabine—Palpitations—Mycophenolate mofetil—psoriasis	0.00111	0.00113	CcSEcCtD
Vidarabine—Arrhythmia—Triamcinolone—psoriasis	0.0011	0.00113	CcSEcCtD
Vidarabine—Vision blurred—Prednisolone—psoriasis	0.0011	0.00112	CcSEcCtD
Vidarabine—Loss of consciousness—Mycophenolate mofetil—psoriasis	0.0011	0.00112	CcSEcCtD
Vidarabine—Chest pain—Cyclosporine—psoriasis	0.00109	0.00112	CcSEcCtD
Vidarabine—Cough—Mycophenolate mofetil—psoriasis	0.00109	0.00112	CcSEcCtD
Vidarabine—Anxiety—Cyclosporine—psoriasis	0.00109	0.00111	CcSEcCtD
Vidarabine—Convulsion—Mycophenolate mofetil—psoriasis	0.00108	0.00111	CcSEcCtD
Vidarabine—Hypertension—Mycophenolate mofetil—psoriasis	0.00108	0.0011	CcSEcCtD
Vidarabine—Discomfort—Cyclosporine—psoriasis	0.00108	0.0011	CcSEcCtD
Vidarabine—Acute coronary syndrome—Prednisone—psoriasis	0.00107	0.00109	CcSEcCtD
Vidarabine—Dry mouth—Cyclosporine—psoriasis	0.00107	0.00109	CcSEcCtD
Vidarabine—Angioedema—Prednisolone—psoriasis	0.00107	0.00109	CcSEcCtD
Vidarabine—Chest pain—Mycophenolate mofetil—psoriasis	0.00107	0.00109	CcSEcCtD
Vidarabine—Myocardial infarction—Prednisone—psoriasis	0.00106	0.00109	CcSEcCtD
Vidarabine—Anxiety—Mycophenolate mofetil—psoriasis	0.00106	0.00109	CcSEcCtD
Vidarabine—Discomfort—Mycophenolate mofetil—psoriasis	0.00105	0.00108	CcSEcCtD
Vidarabine—Dysgeusia—Triamcinolone—psoriasis	0.00105	0.00107	CcSEcCtD
Vidarabine—Anaphylactic shock—Cyclosporine—psoriasis	0.00105	0.00107	CcSEcCtD
Vidarabine—Syncope—Prednisolone—psoriasis	0.00105	0.00107	CcSEcCtD
Vidarabine—Dry mouth—Mycophenolate mofetil—psoriasis	0.00104	0.00106	CcSEcCtD
Vidarabine—Angioedema—Hydrocortisone—psoriasis	0.00104	0.00106	CcSEcCtD
Vidarabine—Back pain—Triamcinolone—psoriasis	0.00104	0.00106	CcSEcCtD
Vidarabine—Loss of consciousness—Prednisolone—psoriasis	0.00103	0.00105	CcSEcCtD
Vidarabine—Syncope—Hydrocortisone—psoriasis	0.00102	0.00105	CcSEcCtD
Vidarabine—Dizziness—Hydroxyurea—psoriasis	0.00102	0.00104	CcSEcCtD
Vidarabine—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.00102	0.00104	CcSEcCtD
Vidarabine—Hyperhidrosis—Cyclosporine—psoriasis	0.00101	0.00103	CcSEcCtD
Vidarabine—Convulsion—Prednisolone—psoriasis	0.00101	0.00103	CcSEcCtD
Vidarabine—Hypertension—Prednisolone—psoriasis	0.00101	0.00103	CcSEcCtD
Vidarabine—Shock—Mycophenolate mofetil—psoriasis	0.00101	0.00103	CcSEcCtD
Vidarabine—Loss of consciousness—Hydrocortisone—psoriasis	0.001	0.00102	CcSEcCtD
Vidarabine—Arrhythmia—Betamethasone—psoriasis	0.001	0.00102	CcSEcCtD
Vidarabine—Arrhythmia—Dexamethasone—psoriasis	0.001	0.00102	CcSEcCtD
Vidarabine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000997	0.00102	CcSEcCtD
Vidarabine—Bradycardia—Prednisone—psoriasis	0.000992	0.00101	CcSEcCtD
Vidarabine—Convulsion—Hydrocortisone—psoriasis	0.000988	0.00101	CcSEcCtD
Vidarabine—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000988	0.00101	CcSEcCtD
Vidarabine—Hypertension—Hydrocortisone—psoriasis	0.000985	0.00101	CcSEcCtD
Vidarabine—Vomiting—Hydroxyurea—psoriasis	0.000983	0.001	CcSEcCtD
Vidarabine—Discomfort—Prednisolone—psoriasis	0.000982	0.001	CcSEcCtD
Vidarabine—Angioedema—Triamcinolone—psoriasis	0.000981	0.001	CcSEcCtD
Vidarabine—Abdominal discomfort—Methotrexate—psoriasis	0.000976	0.000997	CcSEcCtD
Vidarabine—Rash—Hydroxyurea—psoriasis	0.000975	0.000996	CcSEcCtD
Vidarabine—Dermatitis—Hydroxyurea—psoriasis	0.000974	0.000995	CcSEcCtD
Vidarabine—Headache—Hydroxyurea—psoriasis	0.000968	0.000989	CcSEcCtD
Vidarabine—Anxiety—Hydrocortisone—psoriasis	0.000968	0.000989	CcSEcCtD
Vidarabine—Syncope—Triamcinolone—psoriasis	0.000963	0.000984	CcSEcCtD
Vidarabine—Discomfort—Hydrocortisone—psoriasis	0.000959	0.00098	CcSEcCtD
Vidarabine—Hypotension—Mycophenolate mofetil—psoriasis	0.000955	0.000975	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000954	0.000975	CcSEcCtD
Vidarabine—Anaphylactic shock—Prednisolone—psoriasis	0.000953	0.000974	CcSEcCtD
Vidarabine—Loss of consciousness—Triamcinolone—psoriasis	0.000944	0.000964	CcSEcCtD
Vidarabine—Paraesthesia—Cyclosporine—psoriasis	0.00094	0.000961	CcSEcCtD
Vidarabine—Shock—Prednisolone—psoriasis	0.000938	0.000958	CcSEcCtD
Vidarabine—Cough—Triamcinolone—psoriasis	0.000937	0.000957	CcSEcCtD
Vidarabine—Dyspnoea—Cyclosporine—psoriasis	0.000934	0.000954	CcSEcCtD
Vidarabine—Somnolence—Cyclosporine—psoriasis	0.000931	0.000951	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000931	0.000951	CcSEcCtD
Vidarabine—Anaphylactic shock—Hydrocortisone—psoriasis	0.000931	0.000951	CcSEcCtD
Vidarabine—Convulsion—Triamcinolone—psoriasis	0.00093	0.000951	CcSEcCtD
Vidarabine—Tachycardia—Prednisolone—psoriasis	0.00093	0.00095	CcSEcCtD
Vidarabine—Asthenia—Mycophenolic acid—psoriasis	0.000929	0.000949	CcSEcCtD
Vidarabine—Hypertension—Triamcinolone—psoriasis	0.000927	0.000947	CcSEcCtD
Vidarabine—Hyperhidrosis—Prednisolone—psoriasis	0.000921	0.000941	CcSEcCtD
Vidarabine—Nausea—Hydroxyurea—psoriasis	0.000918	0.000938	CcSEcCtD
Vidarabine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000917	0.000937	CcSEcCtD
Vidarabine—Shock—Hydrocortisone—psoriasis	0.000916	0.000936	CcSEcCtD
Vidarabine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000911	0.000931	CcSEcCtD
Vidarabine—Tachycardia—Hydrocortisone—psoriasis	0.000908	0.000928	CcSEcCtD
Vidarabine—Somnolence—Mycophenolate mofetil—psoriasis	0.000908	0.000928	CcSEcCtD
Vidarabine—Drowsiness—Methotrexate—psoriasis	0.000907	0.000927	CcSEcCtD
Vidarabine—Flushing—Prednisone—psoriasis	0.000905	0.000924	CcSEcCtD
Vidarabine—Discomfort—Triamcinolone—psoriasis	0.000903	0.000923	CcSEcCtD
Vidarabine—Hyperhidrosis—Hydrocortisone—psoriasis	0.0009	0.000919	CcSEcCtD
Vidarabine—Pain—Cyclosporine—psoriasis	0.000896	0.000915	CcSEcCtD
Vidarabine—Dry mouth—Triamcinolone—psoriasis	0.000894	0.000914	CcSEcCtD
Vidarabine—Angioedema—Dexamethasone—psoriasis	0.00089	0.00091	CcSEcCtD
Vidarabine—Angioedema—Betamethasone—psoriasis	0.00089	0.00091	CcSEcCtD
Vidarabine—Anaphylactic shock—Triamcinolone—psoriasis	0.000876	0.000895	CcSEcCtD
Vidarabine—Syncope—Dexamethasone—psoriasis	0.000874	0.000893	CcSEcCtD
Vidarabine—Syncope—Betamethasone—psoriasis	0.000874	0.000893	CcSEcCtD
Vidarabine—Pain—Mycophenolate mofetil—psoriasis	0.000874	0.000893	CcSEcCtD
Vidarabine—Arrhythmia—Prednisone—psoriasis	0.000871	0.00089	CcSEcCtD
Vidarabine—Sweating—Methotrexate—psoriasis	0.00087	0.000889	CcSEcCtD
Vidarabine—Hypotension—Hydrocortisone—psoriasis	0.00087	0.000889	CcSEcCtD
Vidarabine—Shock—Triamcinolone—psoriasis	0.000862	0.000881	CcSEcCtD
Vidarabine—Loss of consciousness—Dexamethasone—psoriasis	0.000856	0.000875	CcSEcCtD
Vidarabine—Loss of consciousness—Betamethasone—psoriasis	0.000856	0.000875	CcSEcCtD
Vidarabine—Dizziness—Mycophenolic acid—psoriasis	0.000856	0.000875	CcSEcCtD
Vidarabine—Paraesthesia—Prednisolone—psoriasis	0.000856	0.000874	CcSEcCtD
Vidarabine—Tachycardia—Triamcinolone—psoriasis	0.000855	0.000874	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000848	0.000866	CcSEcCtD
Vidarabine—Hyperhidrosis—Triamcinolone—psoriasis	0.000847	0.000866	CcSEcCtD
Vidarabine—Convulsion—Betamethasone—psoriasis	0.000844	0.000863	CcSEcCtD
Vidarabine—Convulsion—Dexamethasone—psoriasis	0.000844	0.000863	CcSEcCtD
Vidarabine—Hypertension—Dexamethasone—psoriasis	0.000841	0.00086	CcSEcCtD
Vidarabine—Hypertension—Betamethasone—psoriasis	0.000841	0.00086	CcSEcCtD
Vidarabine—Paraesthesia—Hydrocortisone—psoriasis	0.000836	0.000854	CcSEcCtD
Vidarabine—Urticaria—Cyclosporine—psoriasis	0.000832	0.00085	CcSEcCtD
Vidarabine—Anxiety—Dexamethasone—psoriasis	0.000827	0.000845	CcSEcCtD
Vidarabine—Anxiety—Betamethasone—psoriasis	0.000827	0.000845	CcSEcCtD
Vidarabine—Vomiting—Mycophenolic acid—psoriasis	0.000823	0.000841	CcSEcCtD
Vidarabine—Discomfort—Dexamethasone—psoriasis	0.00082	0.000837	CcSEcCtD
Vidarabine—Discomfort—Betamethasone—psoriasis	0.00082	0.000837	CcSEcCtD
Vidarabine—Rash—Mycophenolic acid—psoriasis	0.000816	0.000834	CcSEcCtD
Vidarabine—Dermatitis—Mycophenolic acid—psoriasis	0.000815	0.000833	CcSEcCtD
Vidarabine—Pain—Prednisolone—psoriasis	0.000815	0.000833	CcSEcCtD
Vidarabine—Urticaria—Mycophenolate mofetil—psoriasis	0.000812	0.000829	CcSEcCtD
Vidarabine—Headache—Mycophenolic acid—psoriasis	0.000811	0.000829	CcSEcCtD
Vidarabine—Vision blurred—Prednisone—psoriasis	0.0008	0.000817	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000798	0.000816	CcSEcCtD
Vidarabine—Pain—Hydrocortisone—psoriasis	0.000796	0.000813	CcSEcCtD
Vidarabine—Anaphylactic shock—Betamethasone—psoriasis	0.000795	0.000813	CcSEcCtD
Vidarabine—Anaphylactic shock—Dexamethasone—psoriasis	0.000795	0.000813	CcSEcCtD
Vidarabine—Paraesthesia—Triamcinolone—psoriasis	0.000787	0.000804	CcSEcCtD
Vidarabine—Shock—Betamethasone—psoriasis	0.000782	0.000799	CcSEcCtD
Vidarabine—Shock—Dexamethasone—psoriasis	0.000782	0.000799	CcSEcCtD
Vidarabine—Dyspnoea—Triamcinolone—psoriasis	0.000781	0.000798	CcSEcCtD
Vidarabine—Agitation—Prednisone—psoriasis	0.00078	0.000797	CcSEcCtD
Vidarabine—Tachycardia—Betamethasone—psoriasis	0.000776	0.000793	CcSEcCtD
Vidarabine—Tachycardia—Dexamethasone—psoriasis	0.000776	0.000793	CcSEcCtD
Vidarabine—Angioedema—Prednisone—psoriasis	0.000775	0.000792	CcSEcCtD
Vidarabine—Hypersensitivity—Cyclosporine—psoriasis	0.000772	0.000788	CcSEcCtD
Vidarabine—Nausea—Mycophenolic acid—psoriasis	0.000769	0.000786	CcSEcCtD
Vidarabine—Hyperhidrosis—Dexamethasone—psoriasis	0.000769	0.000785	CcSEcCtD
Vidarabine—Hyperhidrosis—Betamethasone—psoriasis	0.000769	0.000785	CcSEcCtD
Vidarabine—Syncope—Prednisone—psoriasis	0.000761	0.000778	CcSEcCtD
Vidarabine—Tinnitus—Methotrexate—psoriasis	0.00076	0.000776	CcSEcCtD
Vidarabine—Urticaria—Prednisolone—psoriasis	0.000757	0.000774	CcSEcCtD
Vidarabine—Cardiac disorder—Methotrexate—psoriasis	0.000756	0.000773	CcSEcCtD
Vidarabine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000753	0.000769	CcSEcCtD
Vidarabine—Asthenia—Cyclosporine—psoriasis	0.000751	0.000768	CcSEcCtD
Vidarabine—Pain—Triamcinolone—psoriasis	0.000749	0.000766	CcSEcCtD
Vidarabine—Loss of consciousness—Prednisone—psoriasis	0.000746	0.000762	CcSEcCtD
Vidarabine—Hypotension—Dexamethasone—psoriasis	0.000743	0.000759	CcSEcCtD
Vidarabine—Hypotension—Betamethasone—psoriasis	0.000743	0.000759	CcSEcCtD
Vidarabine—Urticaria—Hydrocortisone—psoriasis	0.000739	0.000756	CcSEcCtD
Vidarabine—Convulsion—Prednisone—psoriasis	0.000735	0.000751	CcSEcCtD
Vidarabine—Mediastinal disorder—Methotrexate—psoriasis	0.000734	0.00075	CcSEcCtD
Vidarabine—Asthenia—Mycophenolate mofetil—psoriasis	0.000733	0.000749	CcSEcCtD
Vidarabine—Hypertension—Prednisone—psoriasis	0.000733	0.000749	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000725	0.00074	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000725	0.00074	CcSEcCtD
Vidarabine—Anxiety—Prednisone—psoriasis	0.00072	0.000736	CcSEcCtD
Vidarabine—Paraesthesia—Dexamethasone—psoriasis	0.000714	0.00073	CcSEcCtD
Vidarabine—Paraesthesia—Betamethasone—psoriasis	0.000714	0.00073	CcSEcCtD
Vidarabine—Discomfort—Prednisone—psoriasis	0.000714	0.000729	CcSEcCtD
Vidarabine—Hypersensitivity—Prednisolone—psoriasis	0.000702	0.000717	CcSEcCtD
Vidarabine—Urticaria—Triamcinolone—psoriasis	0.000696	0.000711	CcSEcCtD
Vidarabine—Dysgeusia—Methotrexate—psoriasis	0.000694	0.00071	CcSEcCtD
Vidarabine—Dizziness—Cyclosporine—psoriasis	0.000693	0.000708	CcSEcCtD
Vidarabine—Anaphylactic shock—Prednisone—psoriasis	0.000693	0.000708	CcSEcCtD
Vidarabine—Back pain—Methotrexate—psoriasis	0.000686	0.000701	CcSEcCtD
Vidarabine—Hypersensitivity—Hydrocortisone—psoriasis	0.000686	0.000701	CcSEcCtD
Vidarabine—Shock—Prednisone—psoriasis	0.000681	0.000696	CcSEcCtD
Vidarabine—Pain—Dexamethasone—psoriasis	0.00068	0.000695	CcSEcCtD
Vidarabine—Pain—Betamethasone—psoriasis	0.00068	0.000695	CcSEcCtD
Vidarabine—Tachycardia—Prednisone—psoriasis	0.000676	0.000691	CcSEcCtD
Vidarabine—Dizziness—Mycophenolate mofetil—psoriasis	0.000676	0.00069	CcSEcCtD
Vidarabine—Hyperhidrosis—Prednisone—psoriasis	0.000669	0.000684	CcSEcCtD
Vidarabine—Vision blurred—Methotrexate—psoriasis	0.000668	0.000683	CcSEcCtD
Vidarabine—Asthenia—Hydrocortisone—psoriasis	0.000668	0.000682	CcSEcCtD
Vidarabine—Vomiting—Cyclosporine—psoriasis	0.000666	0.00068	CcSEcCtD
Vidarabine—Rash—Cyclosporine—psoriasis	0.00066	0.000675	CcSEcCtD
Vidarabine—Dermatitis—Cyclosporine—psoriasis	0.00066	0.000674	CcSEcCtD
Vidarabine—Headache—Cyclosporine—psoriasis	0.000656	0.00067	CcSEcCtD
Vidarabine—Vomiting—Mycophenolate mofetil—psoriasis	0.00065	0.000664	CcSEcCtD
Vidarabine—Hypersensitivity—Triamcinolone—psoriasis	0.000646	0.00066	CcSEcCtD
Vidarabine—Rash—Mycophenolate mofetil—psoriasis	0.000644	0.000658	CcSEcCtD
Vidarabine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000644	0.000658	CcSEcCtD
Vidarabine—Headache—Mycophenolate mofetil—psoriasis	0.00064	0.000654	CcSEcCtD
Vidarabine—Urticaria—Dexamethasone—psoriasis	0.000632	0.000645	CcSEcCtD
Vidarabine—Urticaria—Betamethasone—psoriasis	0.000632	0.000645	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000631	0.000645	CcSEcCtD
Vidarabine—Dizziness—Prednisolone—psoriasis	0.00063	0.000644	CcSEcCtD
Vidarabine—Asthenia—Triamcinolone—psoriasis	0.000629	0.000642	CcSEcCtD
Vidarabine—Nausea—Cyclosporine—psoriasis	0.000622	0.000636	CcSEcCtD
Vidarabine—Paraesthesia—Prednisone—psoriasis	0.000622	0.000635	CcSEcCtD
Vidarabine—Cough—Methotrexate—psoriasis	0.000619	0.000632	CcSEcCtD
Vidarabine—Dizziness—Hydrocortisone—psoriasis	0.000615	0.000629	CcSEcCtD
Vidarabine—Convulsion—Methotrexate—psoriasis	0.000614	0.000628	CcSEcCtD
Vidarabine—Nausea—Mycophenolate mofetil—psoriasis	0.000607	0.00062	CcSEcCtD
Vidarabine—Chest pain—Methotrexate—psoriasis	0.000604	0.000617	CcSEcCtD
Vidarabine—Rash—Prednisolone—psoriasis	0.000601	0.000614	CcSEcCtD
Vidarabine—Dermatitis—Prednisolone—psoriasis	0.0006	0.000613	CcSEcCtD
Vidarabine—Headache—Prednisolone—psoriasis	0.000597	0.00061	CcSEcCtD
Vidarabine—Discomfort—Methotrexate—psoriasis	0.000597	0.000609	CcSEcCtD
Vidarabine—Vomiting—Hydrocortisone—psoriasis	0.000592	0.000605	CcSEcCtD
Vidarabine—Rash—Hydrocortisone—psoriasis	0.000587	0.0006	CcSEcCtD
Vidarabine—Dermatitis—Hydrocortisone—psoriasis	0.000586	0.000599	CcSEcCtD
Vidarabine—Headache—Hydrocortisone—psoriasis	0.000583	0.000596	CcSEcCtD
Vidarabine—Dizziness—Triamcinolone—psoriasis	0.00058	0.000592	CcSEcCtD
Vidarabine—Anaphylactic shock—Methotrexate—psoriasis	0.000579	0.000591	CcSEcCtD
Vidarabine—Asthenia—Dexamethasone—psoriasis	0.000571	0.000583	CcSEcCtD
Vidarabine—Asthenia—Betamethasone—psoriasis	0.000571	0.000583	CcSEcCtD
Vidarabine—Nausea—Prednisolone—psoriasis	0.000566	0.000578	CcSEcCtD
Vidarabine—Hyperhidrosis—Methotrexate—psoriasis	0.00056	0.000572	CcSEcCtD
Vidarabine—Vomiting—Triamcinolone—psoriasis	0.000557	0.000569	CcSEcCtD
Vidarabine—Nausea—Hydrocortisone—psoriasis	0.000553	0.000565	CcSEcCtD
Vidarabine—Rash—Triamcinolone—psoriasis	0.000553	0.000565	CcSEcCtD
Vidarabine—Dermatitis—Triamcinolone—psoriasis	0.000552	0.000564	CcSEcCtD
Vidarabine—Urticaria—Prednisone—psoriasis	0.00055	0.000562	CcSEcCtD
Vidarabine—Headache—Triamcinolone—psoriasis	0.000549	0.000561	CcSEcCtD
Vidarabine—Hypotension—Methotrexate—psoriasis	0.000541	0.000553	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000527	0.000539	CcSEcCtD
Vidarabine—Dizziness—Betamethasone—psoriasis	0.000526	0.000537	CcSEcCtD
Vidarabine—Dizziness—Dexamethasone—psoriasis	0.000526	0.000537	CcSEcCtD
Vidarabine—Nausea—Triamcinolone—psoriasis	0.000521	0.000532	CcSEcCtD
Vidarabine—Paraesthesia—Methotrexate—psoriasis	0.00052	0.000531	CcSEcCtD
Vidarabine—Dyspnoea—Methotrexate—psoriasis	0.000516	0.000527	CcSEcCtD
Vidarabine—Somnolence—Methotrexate—psoriasis	0.000515	0.000526	CcSEcCtD
Vidarabine—Hypersensitivity—Prednisone—psoriasis	0.00051	0.000521	CcSEcCtD
Vidarabine—Vomiting—Betamethasone—psoriasis	0.000506	0.000517	CcSEcCtD
Vidarabine—Vomiting—Dexamethasone—psoriasis	0.000506	0.000517	CcSEcCtD
Vidarabine—Rash—Betamethasone—psoriasis	0.000501	0.000512	CcSEcCtD
Vidarabine—Rash—Dexamethasone—psoriasis	0.000501	0.000512	CcSEcCtD
Vidarabine—Dermatitis—Betamethasone—psoriasis	0.000501	0.000512	CcSEcCtD
Vidarabine—Dermatitis—Dexamethasone—psoriasis	0.000501	0.000512	CcSEcCtD
Vidarabine—Headache—Dexamethasone—psoriasis	0.000498	0.000509	CcSEcCtD
Vidarabine—Headache—Betamethasone—psoriasis	0.000498	0.000509	CcSEcCtD
Vidarabine—Asthenia—Prednisone—psoriasis	0.000497	0.000508	CcSEcCtD
Vidarabine—Pain—Methotrexate—psoriasis	0.000495	0.000506	CcSEcCtD
Vidarabine—Nausea—Betamethasone—psoriasis	0.000472	0.000483	CcSEcCtD
Vidarabine—Nausea—Dexamethasone—psoriasis	0.000472	0.000483	CcSEcCtD
Vidarabine—Urticaria—Methotrexate—psoriasis	0.00046	0.00047	CcSEcCtD
Vidarabine—Dizziness—Prednisone—psoriasis	0.000458	0.000468	CcSEcCtD
Vidarabine—Vomiting—Prednisone—psoriasis	0.00044	0.00045	CcSEcCtD
Vidarabine—Rash—Prednisone—psoriasis	0.000437	0.000446	CcSEcCtD
Vidarabine—Dermatitis—Prednisone—psoriasis	0.000436	0.000446	CcSEcCtD
Vidarabine—Headache—Prednisone—psoriasis	0.000434	0.000443	CcSEcCtD
Vidarabine—Hypersensitivity—Methotrexate—psoriasis	0.000426	0.000436	CcSEcCtD
Vidarabine—Asthenia—Methotrexate—psoriasis	0.000415	0.000424	CcSEcCtD
Vidarabine—Nausea—Prednisone—psoriasis	0.000411	0.00042	CcSEcCtD
Vidarabine—Dizziness—Methotrexate—psoriasis	0.000383	0.000391	CcSEcCtD
Vidarabine—Vomiting—Methotrexate—psoriasis	0.000368	0.000376	CcSEcCtD
Vidarabine—Rash—Methotrexate—psoriasis	0.000365	0.000373	CcSEcCtD
Vidarabine—Dermatitis—Methotrexate—psoriasis	0.000365	0.000373	CcSEcCtD
Vidarabine—Headache—Methotrexate—psoriasis	0.000363	0.00037	CcSEcCtD
Vidarabine—Nausea—Methotrexate—psoriasis	0.000344	0.000351	CcSEcCtD
